2 results
Antiplatelet Conversion - Switching Between Oral P2Y12 Inhibitors
A, Switching between oral agents in the acute/early phase.
Antiplatelet Conversion ... agents in the acute ... In the acute/early ... of patients who are ... ticagrelor #prasugrel #pharmacology
Myelodysplastic syndromes current treatment algorithm 2018.

From Blood Cancer Journal, Published 24 May 2018

Myelodysplastic syndromes (MDS) are
current treatment algorithm ... clonal evolution to acute ... disease tolerate anemia ... an infection or bleeding ... #algorithm #hematology